Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Issue title: Genomic Approaches to the Study of Breast Cancer
Guest editors: Jeffrey E. Green
Article type: Research Article
Authors: Meltzer, Paul S.
Affiliations: Cancer Genetics Branch, National Human Genome Research Institute, 50 South Drive MSC 8000, Bethesda MD, 20892-8000, USA. E-mail: [email protected] | National Cancer Institute, Bethesda, MD, USA
Abstract: The gene expression profiles of breast cancers can now be determined with microarray technologies which measure the expression of tens of thousands of genes. By applying statistical and bioinformatics tools to gene expression data, tumors can be classified into biologically and clinically relevant categories. In addition to improving tumor classification, gene expression signatures have been identified which are related to BRCA1 and BRCA2 mutation status, ER status, and patient prognosis. Beyond its impact on research into the basic mechanisms of breast tumor progression, continued progress in tumor gene expression profiling appears likely to lead to clinically useful gene expression tests.
DOI: 10.3233/BD-2004-19104
Journal: Breast Disease, vol. 19, no. 1, pp. 23-27, 2004
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]